Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes

A pharmaceutical care program for dyslipidemic patients was designed, implemented, and assessed. The study was conducted during 32 weeks, at three Primary Health Care Centers. One hundred and forty two patients were selected. These patients were randomly assigned to intervention or control groups. I...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Villa, Lorenzo A., Chrismar, Ana M. von, Oyarzún, Carlos, Eujenín, Paloma, Fernández, María E., Quezada, Marcela
Formato: Articulo
Lenguaje:Inglés
Publicado: 2009
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/7777
http://www.latamjpharm.org/trabajos/28/3/LAJOP_28_3_1_13_3854527IO1.pdf
Aporte de:
id I19-R120-10915-7777
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Farmacia
programa de cuidados farmaceúticos; centros primarios de salud; tratamiento y calidad de vida
Farmacología
Efecto de las drogas
Efectos fisiológicos de las drogas
pharmaceutical care program; primary health care centers; treatment and quality of life
spellingShingle Farmacia
programa de cuidados farmaceúticos; centros primarios de salud; tratamiento y calidad de vida
Farmacología
Efecto de las drogas
Efectos fisiológicos de las drogas
pharmaceutical care program; primary health care centers; treatment and quality of life
Villa, Lorenzo A.
Chrismar, Ana M. von
Oyarzún, Carlos
Eujenín, Paloma
Fernández, María E.
Quezada, Marcela
Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes
topic_facet Farmacia
programa de cuidados farmaceúticos; centros primarios de salud; tratamiento y calidad de vida
Farmacología
Efecto de las drogas
Efectos fisiológicos de las drogas
pharmaceutical care program; primary health care centers; treatment and quality of life
description A pharmaceutical care program for dyslipidemic patients was designed, implemented, and assessed. The study was conducted during 32 weeks, at three Primary Health Care Centers. One hundred and forty two patients were selected. These patients were randomly assigned to intervention or control groups. Intervention group patients received care twice a month and were surveyed to assess their knowledge about their illness and medications, adherence to drug therapy, and quality of life. Possible drug related problems (DRP) were identified, the most frequent being that medication was not taken according to medical indication. Total cholesterol, HDL-cholesterol, LDL-cholesterol, and triglycerides were measured every two months, with results showing significant improvements in the intervention group’s total cholesterol, LDL-cholesterol (p < 0.0001) and triglycerides (p = 0.009), knowledge of the illness (p < 0.0001), adherence to pharmacological treatment (p < 0.0001), and quality of life (p < 0.0001). Pharmaceutical care prevents and solves drug-related problems and improves patients’ clinical parameters, adherence to medical treatment and quality of life.
format Articulo
Articulo
author Villa, Lorenzo A.
Chrismar, Ana M. von
Oyarzún, Carlos
Eujenín, Paloma
Fernández, María E.
Quezada, Marcela
author_facet Villa, Lorenzo A.
Chrismar, Ana M. von
Oyarzún, Carlos
Eujenín, Paloma
Fernández, María E.
Quezada, Marcela
author_sort Villa, Lorenzo A.
title Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes
title_short Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes
title_full Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes
title_fullStr Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes
title_full_unstemmed Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes
title_sort pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes
publishDate 2009
url http://sedici.unlp.edu.ar/handle/10915/7777
http://www.latamjpharm.org/trabajos/28/3/LAJOP_28_3_1_13_3854527IO1.pdf
work_keys_str_mv AT villalorenzoa pharmaceuticalcareprogramfordyslipidemicpatientsatthreeprimaryhealthcarecentersimpactsandoutcomes
AT chrismaranamvon pharmaceuticalcareprogramfordyslipidemicpatientsatthreeprimaryhealthcarecentersimpactsandoutcomes
AT oyarzuncarlos pharmaceuticalcareprogramfordyslipidemicpatientsatthreeprimaryhealthcarecentersimpactsandoutcomes
AT eujeninpaloma pharmaceuticalcareprogramfordyslipidemicpatientsatthreeprimaryhealthcarecentersimpactsandoutcomes
AT fernandezmariae pharmaceuticalcareprogramfordyslipidemicpatientsatthreeprimaryhealthcarecentersimpactsandoutcomes
AT quezadamarcela pharmaceuticalcareprogramfordyslipidemicpatientsatthreeprimaryhealthcarecentersimpactsandoutcomes
bdutipo_str Repositorios
_version_ 1764820485071175681